Vonage Pharma’s Rosuvastatin 20 mg tablets deliver maximum-efficacy treatment for severe hypercholesterolemia in Cardiovascular category. As the highest commercially available dose, this GMP-manufactured FDF offers:
Therapeutic Applications:
Severe primary hypercholesterolemia (LDL >190 mg/dL)
High-risk CVD patients requiring aggressive LDL lowering
Genetic dyslipidemias (e.g., familial hypercholesterolemia)
| Characteristic | Specification |
|---|---|
| Dosage Form | Film-coated immediate-release |
| Appearance | Pink, oval, debossed |
| Dissolution | ≥85% in 30 min (pH 6.8) |
| Assay (HPLC) | 98.0–102.0% |
| Related Substances | ≤0.5% |
Shelf life: 24 months at 25°C/60% RH
Packaging:
Alu-Alu blisters (10/30/100 count) – UV-protective
HDPE bottles (100/500/1000 count) with tamper-evident seals
Batch sizes: 100K–3M tablets (larger MOQs vs. 10 mg)
Excipients: Lactose-free formulation available
Quality controls:
Hardness 60-100 N (reinforced for high-dose integrity)
Friability ≤0.8%
Active ASMF
US DMF Type II available
Prequalified excipients: Microcrystalline cellulose (PH-102), croscarmellose sodium
Lead time: 6 weeks (express options for 1M+ units)
Cold-chain logistics: For tropical climates
ANDA acceleration: Comparative dissolution profiles
Cost advantage: 18% lower COGS vs. EU competitors
High-dose preference: 72% of cardiologists prescribe 20 mg for severe cases
Bulk packaging: 1,000-count bottles for institutional use
WHO-compliant documentation
Halal/Kosher certification available
MOQ: 100,000 tablets
Samples: 50 units for quality validation
Documentation: Batch records, CoA, GMP certificates
We understand the complexities and challenges you face in the healthcare industry. That’s why we’re dedicated to providing innovative solutions and insightful knowledge to help you achieve your goals.
Your input is crucial in helping us understand your needs and deliver the most relevant support: